tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Michael Nedelcovych, 10 are a BUY (90.91%), 1 are a HOLD (9.09%).
Analyst Michael Nedelcovych, currently employed at TD COWEN, carries an average stock price target met ratio of 77.78% that have a potential upside of 15.78% achieved within 202 days.
Michael Nedelcovych’s has documented 22 price targets and ratings displayed on 2 stocks.
Most recent stock forecast was given on NVO, Novo Nordisk A/S at 19-Aug-2025.
Analyst best performing recommendations are on TAK (TAKEDA PHARMACEUTICAL CO LTD ADR).
The best stock recommendation documented was for NVO (NOVO NORDISK A/S) at 12/4/2023. The price target of $115 was fulfilled within 67 days with a profit of $17.85 (18.37%) receiving and performance score of 2.74.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 19-Jul-2024
$41
$-7.07 (-14.71%)
$54
Hold Since 14-May-2025
$46
$-2.07 (-4.31%)
$50
What Year was the first public recommendation made by Michael Nedelcovych?
